Literature DB >> 10202984

Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation.

J Mally1, T W Stone.   

Abstract

Transcranial magnetic stimulation has been used in the diagnosis of neurological lesions, but has also been shown to be useful in the treatment of depression. We have now examined the effect of applying transcranial magnetic stimulation daily for 10 days in a sample of 10 patients with Parkinson's disease in whom maximal benefit was being obtained from drug therapy. The subjects were followed for six months and showed significant improvements over this period when assessed using a range of measures. It is suggested that transcranial magnetic stimulation may be a valuable technique in the treatment or adjunct treatment of Parkinsonism, possibly by inducing changes in brain monoamine levels.

Entities:  

Mesh:

Year:  1999        PMID: 10202984     DOI: 10.1016/s0022-510x(98)00318-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Depression in Parkinson's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 2.  Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.

Authors:  F Fregni; D K Simon; A Wu; A Pascual-Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.

Authors:  Antonio P Strafella; Ji Hyun Ko; Oury Monchi
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

Review 4.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 5.  Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review.

Authors:  Clara Sanches; Chloé Stengel; Juliette Godard; Justine Mertz; Marc Teichmann; Raffaella Migliaccio; Antoni Valero-Cabré
Journal:  Front Aging Neurosci       Date:  2021-01-20       Impact factor: 5.750

Review 6.  Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

Authors:  Matthew Vonloh; Robert Chen; Benzi Kluger
Journal:  Parkinsonism Relat Disord       Date:  2013-03-07       Impact factor: 4.891

7.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

8.  Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study.

Authors:  Tim Wagner; Uri Eden; Felipe Fregni; Antoni Valero-Cabre; Ciro Ramos-Estebanez; Valerie Pronio-Stelluto; Alan Grodzinsky; Markus Zahn; Alvaro Pascual-Leone
Journal:  Exp Brain Res       Date:  2008-01-10       Impact factor: 1.972

Review 9.  Noninvasive brain stimulation for Parkinson's disease and dystonia.

Authors:  Allan D Wu; Felipe Fregni; David K Simon; Choi Deblieck; Alvaro Pascual-Leone
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

10.  Electromagnetic field stimulation potentiates endogenous myelin repair by recruiting subventricular neural stem cells in an experimental model of white matter demyelination.

Authors:  Mohammad Amin Sherafat; Motahareh Heibatollahi; Somayeh Mongabadi; Fatemeh Moradi; Mohammad Javan; Abolhassan Ahmadiani
Journal:  J Mol Neurosci       Date:  2012-05-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.